z-logo
open-access-imgOpen Access
ARHGAP18: A Flow‐Responsive Gene That Regulates Endothelial Cell Alignment and Protects Against Atherosclerosis
Author(s) -
Lay Angelina J.,
Coleman Paul R.,
FormazPreston Ann,
Ting Ka Ka,
Roediger Ben,
Weninger Wolfgang,
Schwartz Martin A.,
Vadas Mathew A.,
Gamble Jennifer R.
Publication year - 2019
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.118.010057
Subject(s) - medicine , apolipoprotein b , phenotype , mutant , endothelial stem cell , nitric oxide , intracellular , microbiology and biotechnology , endothelium , endothelial dysfunction , gene , endocrinology , in vitro , biology , biochemistry , cholesterol
Background Vascular endothelial cell (EC) alignment in the direction of flow is an adaptive response that protects against aortic diseases, such as atherosclerosis. The Rho GTP ases are known to regulate this alignment. Herein, we analyze the effect of ARHGAP 18 on the regulation of EC alignment and examine the effect of ARHGAP 18 deficiency on the development of atherosclerosis in mice. Methods and Results We used in vitro analysis of ECs under flow conditions together with apolipoprotein E −/− Arhgap 18 −/− double‐mutant mice to study the function of ARHGAP 18 in a high‐fat diet–induced model of atherosclerosis. Depletion of ARHGAP 18 inhibited the alignment of ECs in the direction of flow and promoted inflammatory phenotype, as evidenced by disrupted junctions and increased expression of nuclear factor‐κB and intercellular adhesion molecule‐1 and decreased endothelial nitric oxide synthase. Mice with double deletion in ARHGAP 18 and apolipoprotein E and fed a high‐fat diet show early onset of atherosclerosis, with lesions developing in atheroprotective regions. Conclusions ARHGAP 18 is a protective gene that maintains EC alignments in the direction of flow. Deletion of ARHGAP 18 led to loss of EC ability to align and promoted atherosclerosis development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here